Angioimmunoblastic T-cell LymphomaSymptoms, Doctors, Treatments, Advances & More
Angioimmunoblastic T-cell Lymphoma Overview
Learn About Angioimmunoblastic T-cell Lymphoma
Mamiko Yanagimoto-Sakata practices practicing medicine in Tsukuba, Japan. Ms. Yanagimoto-Sakata is rated as an Elite expert by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Bone Marrow Transplant, and Bone Graft.
Emmanuel Bachy practices practicing medicine in Lyon, France. Mr. Bachy is rated as an Elite expert by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Kidney Transplant.
Fred & Pamela Buffett Cancer Center - Nebraska Medical Center
Julie Vose is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. Dr. Vose is rated as a Distinguished provider by MediFind in the treatment of Angioimmunoblastic T-cell Lymphoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Vose is currently accepting new patients.
Summary: This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincrist...
Summary: RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.


